↑ Volver a Investigación

Investigación: La salud cardiovascular y el Aceite de Coco

Un gran número de estudios muestran una correlación directa entre las infecciones bacterianas y virales crónicas de grado bajo y las enfermedades coronarias.Los principales culpables son el Chlamydia pneumoniae, citomegalovirus y Helicobacter pylori. Cada uno de estos organismos patógenos, así como muchos otros, son eliminados por los ácidos grasos de cadena media presentes en el Aceite de Coco. Por lo tanto, podemos concluir que el Aceite de Coco, en efecto, puede reducir el riesgo de enfermedades cardiovasculares.

Influence of coconut oil administration on some hematologic and metabolic parameters in pregnant rats. J Matern Fetal Neonatal Med. 2011 Oct;24(10):1254-8. Epub  2011 Jul 7.

In vivo antinociceptive and anti-inflammatory activities of dried and fermented processed virgin coconut oil. Med Princ Pract. 2011;20(3):231-6. Epub 2011 Mar 29.

Coconut oil is associated with a beneficial lipid profile in pre-menopausal women in the Philippines. Asia Pac J Clin Nutr. 2011;20(2):190-5.

Dietary fatty acids and oxidative stress in the heart mitochondria. Mitochondrion. 2011 Jan;11(1):97-103. Epub 2010 Aug 5.

Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides .  Ann Nutr Metab. 2010;56(3):170-5.

Consumption of coconut milk did not increase cardiovascular disease risk in mice, International Journal of Current Research Vol. 6, pp.063-064, July, 2010 6,

Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010 Oct;45(10):893-905. Epub 2010 Mar 31.

Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oil. Pharm Biol. 2010 Feb;48(2):151-7.

A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pac J Clin Nutr. 2009;18(3):351-8.

Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010 Mar;61(3):208-12. 2009 Nov 30.

Medium-and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects. Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Sep;43(9):765-71.

A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. Ann N Y Acad Sci. 2009 Aug;1171:377-84.

Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. 2009 Jul;44(7):593-601. Epub 2009 May 13.

Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52.

The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations. Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H136-44. Epub 2008 May 2.

Medium-chain fatty acids as metabolic therapy in cardiac disease. 2008 Apr;22(2):97-106.

The effect of virgin coconut oil on the cholesterol level of patients with hypercholesterolemia. Fil Fam Phy. 2008 Jan-Mar 46(1):9-17.

Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91.

Anti-inflammatory activity of virgin coconut oil. Philipp J Intern Med. 2007;Mar-Apr 45(2):85-88.

Chylopericardium as a complication of cardiac surgery: report of two cases and review of the literature. Srp Arh Celok Lek. 2007 Jan-Feb;135(1-2):88-91.

Coconut fats. Ceylon Med J. 2006 Jun;51(2):47-51.

Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1425-36. Epub 2004 Nov 18.

Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir. Am J Physiol. 1995 Sep;269(3 Pt 2):R630-40.

The antioxidant effect of virgin coconut oil on lipid peroxidation . Philipp J Intern Med. 2005 Jul-Aug 43(4):199-204.

Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem. 2004 Sep;37(9):830-5

Comparative Study of Coconut Oil, Soybean Oil, and Hydrogenated Soybean Oil. PJCS. 2004;24

A diet rich in coconut oil reduces diurnal postprandial variations in circulating tissue plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women. J. Nutr. 2003;133:3422-3427.

Antibiotic treatment of atherosclerosis. Curr Opin Lipidol. 2003 Dec;14(6):605-14.

Coconut Oil: Atherogenic or Not? (What therefore causes Atherosclerosis?). Philippine Journal of Cardiology. 2003 July-Sept; 31(3):97-104.

Octanoate Inhibits Triglyceride Synthesis in 3T3-L1 and Human Adipocytes, The American Society for Nutritional Sciences, J. Nutr.  133:2512-2518, August 2003

Chronic infection and coronary artery disease. Cardiol Clin. 2003 Aug;21(3):333-62.

Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology.  Int J Cardiol. 2003 Jun;89(2-3):273-9.

Effects of dietary medium-chain triacylglycerols on serum lipoproteins and biochemical parameters in healthy men. Biosci Biotechnol Biochem. 2002 Aug;66(8):1713-8

Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes. Endocr Pract. 2002 May-Jun;8(3):177-83.

Secondary prevention of coronary artery disease with antimicrobials: current status and future directions. Am J Cardiovasc Drugs. . 2002;2(2):107-18.

Chronic infections and atherosclerosis. J Med Assoc Thai. 2001 Dec;84 Suppl 3:S650-7.

Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000 Jul 11;163(1);49-56.

The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. Clin Virol 2000 Feb;16(1):17-24.

Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000 Jan 15;85(2):140-6.

A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post-ingestion plasma triglyceride levels in healthy men. Altern Med Rev 1999 Feb;4(1):23-8.

Inverse association of dietary fat with development of ischemic stroke in men. JAMA 1997 December;278(24):2145-50.

The role of coconut and coconut oil in coronary heart disease in Kerala, south India. Trop Doct. 1997 Oct;27(4):215-7.

Chronic infections and coronary heart disease: is there a link? Lancet, 1997 Aug;350(9075):430-37.

Review: nutritional support for patients with cirrhosis. J Gastroenterol Hepatol. 1997 Apr;12(4):282-6.

Coconut oil consumption and coronary heart disease. Philipp J Intern Med. 1992 May-Jun; 30(3):165-171.

Lipid patterns and dietary habits of healthy subjects living in urban, suburban and rural areas. áreas. Ceylon Med J. 1991 Mar;36(1):9-16.

A reevaluation of coconut oil’s effect on serum cholesterol and atherogenesis. J Philipp Med Assoc.1989; 65(1):144-152.

Coconut oil revisited. J Philipp Med Assoc. 1988;64(4):140-142.

Medium chain triglycerides (MCT) in aging and arteriosclerosis. J Environ Pathol Toxicol Oncol. 1986 Mar-Apr;6(3-4):115-21.

Lee, SM, et al. Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse. Biochem Med 1985;33:104-109.

Longitudinal analysis of the relationship between blood pressure and migration: the Tokelau Island Migrant Study. Am J Epidemiol. 1985 Aug;122(2):291-301.

Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr. 1981 Aug;34(8):1552-61.

The Tokelau Island Migrant Study: serum lipid concentration in two environments. J Chronic Dis. 1981;34(2-3):45-55.

Chylothorax as a manifestation of rheumatic mitral stenosis: its postoperative management with a diet of medium-chain triglycerides. Chest 1978;73;672-673

Long-term effect of medium-chain triglyceride on hepatic enzymes catalyzing lipogenesis and cholesterogenesis in rats. J Nutr Sci Vitaminol (Tokyo).  1977;23(1):43-51.

Studies on Fatty Acid Composition of Adipose Tissue and Blood Lipids of Polynesians. J Am. Clin. Nutr. 1969 May; 22(5):594-605.

Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate- accentuated lipemia. J Lab Clin Med 1965;66:912-926.

Effect of a saturated medium-chain triglyceride on serum-lipids in man. Lancet. 1960 May 21;1(7134):1105-8.